University of Illinois at ChicagoDisclosures
Dr. Goldstein is or has received consulting fees, honoraria, grant payments, and/or contracting fees from the following companies: Amgen, Astellas Pharma US, AstraZeneca, Given, Glaxo Smith Klein, Horizon, Logistical Therapeutics, Merck, Novartis, Pfizer, PLX, Pozen, Proctor and Gamble, Takeda/Sucampo, TAP, Wyeth.
Dr. Jay L. Goldstein is a professor of medicine and vice head of clinical affairs in the department of medicine at the University of Illinois at Chicago College of Medicine, in addition to his duties as a staff physician at the University of Illinois Hospital and the Jesse Brown VA Medical Center, also in Chicago. Dr. Goldstein’s clinical interests include the practice of general gastroenterology, with a special interest in caring for patients with esophageal diseases including gastro-esophageal reflux diseases (GERD) and diseases of the upper gastrointestinal tract such as peptic ulcer disease. He also has specific interest in irritable bowel syndrome. Dr. Goldstein’s research interests include evaluating and optimizing the diagnostic and therapeutic approaches to patients with GERD and peptic ulcer disease, with a focus on understanding how drugs such as non-steroidal anti-inflammatory agents (NSAIDs) cause ulcers in the stomach and small intestine. He has also participated in many trials comparing the safety profile of NSAIDs to the newer Cox-2 specific inhibitors. Over the past 10 years, Dr. Goldstein has taken a strong interest in conducting studies in the area of so-called “outcomes research.”
You need to be logged in to save this episode to a playlist.